Quick Answer
Arcadia Biosciences, Inc. reported Revenue (ASC 606) of $4.86 million for fiscal year 2025.
Arcadia Biosciences, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $4.86M | -3.7% |
| 2024 | $5.04M | +13.3% |
| 2023 | $4.45M | -40.0% |
| 2022 | $7.42M | +9.4% |
| 2021 | $6.78M | -15.6% |
| 2020 | $8.03M | +587.3% |
| 2019 | $1.17M | -20.2% |
| 2018 | $1.46M | -63.6% |
| 2017 | $4.03M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.30M | -15.3% | -10.5% |
| June 30, 2025 | $1.46M | +11.4% | +21.2% |
| March 31, 2025 | $1.20M | +21.6% | -21.9% |
| September 30, 2024 | $1.54M | +18.4% | +17.7% |
| June 30, 2024 | $1.31M | +0.7% | +32.3% |
| March 31, 2024 | $987.0K | -19.9% | -24.0% |
| September 30, 2023 | $1.30M | -17.3% | +0.1% |
| June 30, 2023 | $1.30M | -66.4% | +5.3% |
- Arcadia Biosciences, Inc. showed a decrease of -3.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, Arcadia Biosciences, Inc.’s revenue (asc 606) has grown by 20.7% (from $4.03 million to $4.86 million).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: